MEGAN DONNELLY: Open Payments
NPI 1578815759 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 35 payments from 6 companies in 2025. Trend: 2023 $222 · 2024 $501 · 2025 $521
Food & beverage: $436Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $272 |
| ABBVIE INC. | 11 | $144 |
| GENZYME CORPORATION | 1 | $35 |
| Organon LLC | 4 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
Products named: TREMFYA, RINVOQ, DUPIXENT, SKYRIZI, TALTZ, VTAMA.
Industry payments across WA — which companies pay providers there.
